Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
KPTI: Karyopharm Therapeutics Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
KPTI
The Story
KPTI
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
-0.5% / yr
Operating margin
-55.7%
ROIC
-177.8%
Financially safe
Stretched
Debt / equity
-0.87×
Interest coverage
-1.8×
Current ratio
1.08×
Karyopharm Therapeutics Inc.
KPTI
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Karyopharm Therapeutics Inc.
KPTI
NASDAQ
·
USD
·
Closed
$1.92
−72.61%
$1.92
−$5.09 (72.61%)
52W Range
1th
pctl
Volume
38.88×
avg
Mkt Cap
43.51M
USD
P/E
-0.1
TTM
Div Yield
–
ann
52W Range
1th
pctl
Volume
38.88×
avg
Market Cap
43.51M
USD
P/E Ratio
-0.1
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings